NCT05885269Phase 1Completed
Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata
Comparative Efficacy of Tacrolimus 0.1% and Clobetasol Propionate 0.05% in the Treatment of Alopecia Areata
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Phase 1
- Sponsor
- Combined Military Hospital Abbottabad
- Participants (registry)
- 70
- Start
- November 2022
- Primary completion
- April 2023
- Study completion
- April 2023
- Last registry update
- June 2023
- Countries
- Pakistan
Conditions studied: Alopecia Areata
Interventions: Group A applied topical Clobetasol Propionate, Group B applied topical Tacrolimus
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.